Buscar Información sobre COVID-19 y La Reapertura

¿Hay terapias disponibles para tratar COVID-19?

Scientists are currently testing different types of antivirals that work against influenza, HIV, and even Ebola, to see if they are effective against COVID-19 virus.

Remdesivir is one treatment that's been shown in a clinical trial to have an effect on COVID-19. Preliminary results from that trial, which included sites worldwide, found that the drug reduced patients' length of hospital stay by about four days, from 15 days, on average, to 11 days. The ongoing trial did not show the drug had a significant impact on deaths.

Dexamethasone, a cheap, widely available steroid, has been shown to reduce deaths by one-third among patients on mechanical ventilators, and by one-fifth among patients receiving supplemental oxygen by other means.

In addition, there are clinical trials of other drugs, including favipiravir, ribavirin and galidesivir.

The Milken Institute is curating a resource that tracks COVID-19 treatments and vaccine progress.

Drafted: 30 June 2020